Leadership & Management
Stallergenes Greer appoints new country leader for ANZ in an internal promotion
![Stallergenes Greer appoints new country leader for ANZ in an internal promotion](https://www.healthindustryhub.com.au/wp-content/uploads/2024/06/Stallergenes-Greer-appoints-new-country-leader-for-ANZ-in-an-internal-promotion.png)
Leadership & Management: Stallergenes Greer, a biopharmaceutical leader specialising in respiratory, food, and venom allergies, has appointed Rachel Sutherland as Country Manager for Australia & New Zealand. Sutherland has been with the company for four years, most recently serving as the Director of Commercial Operations for ANZ, prior to her promotion.
“I am excited to transition to the role of Country Manager, Australia & New Zealand,” said Sutherland. “Leading a team of ANZ professionals, we are focused on strengthening relationships with HCPs, patient organisations and the peak professional body to expand the awareness of allergen and venom immunotherapy treatments, offering greater access to a range of evidence-based treatments and long-term hope for patients suffering from respiratory and venom allergies.”
With over two decades of experience in pharmaceuticals and healthcare across commercial, sales, marketing, and patient engagement roles, Sutherland’s leadership and business acumen are set to drive growth in the ANZ market.
The company supplies a portfolio of evidence-based allergen and venom immunotherapy treatments, along with diagnostic devices, tailored for the ANZ market.
Recently, the Stallergenes Greer Foundation Science Award for Allergy was bestowed upon Associate Professor Rachel Peters of the Murdoch Children’s Research Institute. Her research addresses the significant link between food allergies and respiratory health, impacting up to 10% of children.
A/Prof Jennifer Koplin from The University of Queensland’s Child Health Research Centre was also honoured by the Foundation for her work on peanut allergies in infants.
These recognitions highlight Stallergenes Greer’s commitment to advancing allergy research and precision medicine.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.
The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
![Insurer premium reform critical to sustain private health sector - Catholic Health Australia](https://www.healthindustryhub.com.au/wp-content/uploads/2024/06/Insurer-premium-reform-critical-to-sustain-private-health-sector.png)
Insurer premium reform critical to sustain private health sector
MedTech & Diagnostics News: The annual private health insurance premium round process must be significantly reformed to protect private healthcare […]
MoreMedical
![Primary care series to address perceived age bias in bowel cancer](https://www.healthindustryhub.com.au/wp-content/uploads/2024/06/Primary-care-series-to-address-perceived-age-bias-in-bowel-cancer.png)
Primary care series to address perceived age bias in bowel cancer
Medical: Studies reveal that younger individuals with bowel cancer often endure a prolonged period of 3 months to 5 years […]
MoreNews & Trends - Pharmaceuticals
![Department of Health rewarded despite law breach: Integrity crisis in public sector exposed](https://www.healthindustryhub.com.au/wp-content/uploads/2024/06/Department-of-Health-rewarded-despite-law-breach-Integrity-crisis-in-public-sector-exposed.png)
Department of Health rewarded despite law breach: Integrity crisis in public sector exposed
A damning report on the state of ethics and integrity in the Australian public sector has revealed widespread non-compliance with […]
More